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Two molecules of the amino acid L-tryptophan are the biosynthetic precursors to a class of natural products
named the ‘‘bisindoles.’’ Hundreds of these bisindole molecules have been isolated from natural sources,
and many of these molecules have potent medicinal properties. Recent studies have clarified the biosyn-
thetic construction of six bisindole molecules, revealing novel enzymatic mechanisms and leading to
combinatorial synthesis of new bisindole compounds. Collectively, these results provide a vantage point
for understanding how much of the diversity of the bisindole class is generated from a small number of
diverging pathways from L-tryptophan, as well as enabling identification of bisindoles that are likely derived
via completely distinct biosynthetic pathways.Introduction
The rich chemical ecology of organisms such as microbes, fungi,
and plants is due in large part to secondary metabolism (Austin
et al., 2008). This secondary branch of biochemistry stands in
contrast to the primary biochemical processes that enable
organisms to convert organic molecules into chemical energy
and to build up carbohydrates, lipids, nucleotides, and amino
acids from simpler precursors (Dewick, 2001a). Secondary
metabolism instead entails making molecules, for instance, for
defense and communication, often in response to changing
environmental conditions. Secondary metabolites, or natural
products, are characteristically diverse, with a cornucopia of
new molecules isolated each year from natural sources. Further,
while primary metabolites are often found throughout the
kingdoms of life, constituting largely conserved biochemical
processes, secondary metabolites can be highly restricted in
their distribution and are thought to play roles in enabling organ-
isms to thrive in niche environments (Austin et al., 2008). Humans
have used these secondary metabolites since prehistoric times
for their own purposes, from mining organisms for medicines
to gathering dye molecules and poisons.
One major class of secondary metabolites are alkaloids, which
are nitrogen-containing molecules derived from amino acids or
purines (Dewick, 2001b). Particularly infamous among alkaloids
are those derived from L-tryptophan molecules, with notable
examples including ergot alkaloids and the synthetic LSD,
whose structure was inspired by the indole alkaloid D-lysergic
acid. A more recently characterized class of L-tryptophan-
derived alkaloids consists of the ‘‘bisindoles’’ (Table 1). These
molecules, generated by the fusion of two molecules of L-trypto-
phan, contain two indole rings in their structures (structure of
indole 1 in Figure 1A). The first reported ‘‘observation’’ of a bisin-
dole molecule was of violacein 21 in the 1880s (Boisbaudran,
1882); the violacein molecule was purified (Strong, 1944) and
synthesized by 1958 (Ballantine et al., 1958). Subsequent mining
of microbial organisms for anticancer natural products led to theChemistry & Bdiscovery of staurosporine 18 (Omura et al., 1977), a kinase inhib-
itor (Ru¨egg and Burgess, 1989), and, later, rebeccamycin 17
(Bush et al., 1987; Nettleton et al., 1985), analogs of which are
DNA-topoisomerase I inhibitors (Bailly et al., 1997). More
recently, terrequinone A 24, structurally related to antitumor, anti-
viral, and antidiabetic compounds (Schneider et al., 2007), was
isolated from a fungus dwelling in the rhizosphere of an Arizona
desert plant (He et al., 2004) and molecules AT2433-A1 38 (Mat-
son et al., 1989) and K252a 39 (Kase et al., 1986) have been re-
ported (Table 1). These six molecules represent the only
bisindoles for which complete biosynthetic information is now
available. They share the presence of two indole rings, but differ
in how these indole rings are connected and in the types of chem-
ical ornamentation, for instance prenylation, chlorination, hydrox-
ylation, and glycosylation, that decorate their skeletons (Table 1).
Beyond these six molecules, hundreds of bisindole molecules
have been isolated and characterized (Higuchi and Kawasaki,
2007), but the mechanisms of their biosyntheses are largely
unexplored. Bisindoles have been isolated from tunicates,
sponges, plant leaves, roots, bark, flowers, algae, fungi, and
myxomycetes (Higuchi and Kawasaki, 2007) and are most
commonly isolated from actinomycetes (Higuchi and Kawasaki,
2007), a class of bacteria known for production of secondary
metabolites (Piepersberg, 1994). Although there are many
reports on bisindole molecules, the focus of research is clear:
most scientists are interested in how bisindoles can be used
as drug molecules. They work to synthesize derivatives, test
medicinal properties, and isolate new molecules from natural
sources (Higuchi and Kawasaki, 2007; Prudhomme, 2004).
Hence, despite the large interest in bisindoles, there is a paucity
of studies on why organisms make bisindoles at all, which may
represent a rich area for study in the next years.
In this review, we discuss the known, diverging pathways that
lead from L-tryptophan molecules to bisindoles. We first discuss
L-tryptophan as a biosynthetic precursor. We then turn our
attention to the biosynthetic pathways that are now welliology 16, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 351
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Compound No. Structure Class
Source Organism
Used to Isolate
Biosynthetic Genes
Known Medicinal
Properties
Biosynthetic
Enzymes
Rebeccamycin 17 Indolo[2,3a]pyrrolo[3,4c]carbazole Lechevalieria
aerocolonigenes
DNA-topoisomerase
I inhibitor
RebF, RebH,
RebO, RebD,
RebP, RebC,
RebG, RebM
AT2433-A1 38 Indolo[2,3a]pyrrolo[3,4c]carbazole Actinomadura
melliaura
Antitumor,
antibacterial
AtmH, AtmA,
AtmO, Atm D,
AtmP, AtmC,
AtmG, AtmM,
AtmM1,
AtmG1; AtmS7,
AtmS8, AtmS9,
AtmS14,
AtmS12,
AtmS13,
AtmS10
Staurosporine 18 Indolo[2,3a]pyrrolo[3,4c]carbazole Streptomyces
sp. TP-A0274
Protein kinase
inhibitor
StaO, StaD,
StaP, StaC,
StaG, StaN,
StaMA, StaMB;
StaA, StaB,
StaE, StaJ, StaI,
StaK
K252a 39 Indolo[2,3a]pyrrolo[3,4c]carbazole Nonomuraea
longicatena
Protein kinase
C inhibitor
InkO, InkD,
InkP, InkE,
InkG, InkC,
InkA, InkL,
InkB, InkH,
InkM
Violacein 21 Violacein Chromobacterium
violaceum
Antibacterial,
antiviral, anticancer,
antileishmanial,
antiulcerogenic
VioA, VioB,
VioE, VioD,
VioC
Terrequinone A 24 Bisindolylquinone Aspergillus
nidulans
Unknown TdiD, TdiA,
TdiC, TdiB,
TdiEunderstood, starting with a discussion of a major class of bisin-
doles, the indolo[2,3-a]pyrrolo[3,4-c]carbazoles 4 (Figure 1D),
which includes rebeccamycin 17, AT2433-A1 38, staurosporine
18, and K252a 39, and then turn to a discussion of a second352 Chemistry & Biology 16, April 24, 2009 ª2009 Elsevier Ltd All rigclass consisting only of violacein 21 and a third class, the bisin-
dolylquinones, which includes terrequinone A 24 (Table 1). Our
focus in these sections is on the enzymes used to make bisin-
doles. One recurring theme that we find is that these biosynthetichts reserved
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inherent reactivity of bisindole intermediates. Simply put, a key
to bisindole biosynthesis is the prevention of spontaneous
decomposition of reactive intermediates to undesired side prod-
ucts and the coordination of enzymatic activities to shuttle highly
reactive species to more stable biosynthetic intermediates on
route to the desired natural products. Using principles discov-
ered from investigation of these three classes of bisindoles, we
then discuss some of the hundreds of bisindoles whose biosyn-
thesis is still unexplored and postulate routes for construction of
some of these molecules. Finally, we reflect on major questions
that still remain about indolo[2,3-a]pyrrolo[3,4-c]carbazole, viola-
cein, and bisindolylquinone biosynthetic pathways and on future
directions of research for biochemists and microbiologists.
L-Tryptophan as a Biosynthetic Building Block
Like other indole alkaloids (O’Connor and Maresh, 2006), naturally
occurring bisindoles are generally thought to be derived from the
Figure 1. L-Tryptophan as a Biosynthetic
Precursor
(A) Indole 1.
(B) Carbazole 2.
(C) Indolo[2,3-a]carbazole 3.
(D) Indolo[2,3-a]pyrrolo[3,4-c]carbazole 4; R = O
or H2.
(E) Didemethylasterriquinone D 5.
(F) The numbered carbons in L-tryptophan are
reactive in electrophilic aromatic substitution
reactions.
(G) Dimerization of indole-3-pyruvate imine at the
C2 carbon to generate the Cb-Cb benzylically
coupled iminophenylpyruvate dimer 10.
(H) Spontaneous reaction of the Cb-Cb benzyli-
cally coupled iminophenylpyruvate dimer 10.
(I) Aryl-aryl coupling of chromopyrrolic acid 11 is
thought to be followed by spontaneous decarbox-
ylations.
(J) The indole nitrogens of the staurosporine agly-
cone 12 are subjected to enzymatically catalyzed
glycosylations.
(K) Alternate reaction of the Cb-Cb benzylically
coupled iminophenylpyruvate dimer10 to generate
a violacein 21 precursor.
(L) Tethering of indole-3-pyruvate as a thioester
generates a nucleophile and an electrophile in the
same molecule.
amino acid L-tryptophan (Sa´nchez et al.,
2006b), and this assumption has indeed
proven true for all characterized bisindole
biosynthetic pathways. L-tryptophan
provides an excellent scaffold for dimer-
ization and derivatization, and consequent
production of bisindole molecules that, via
distinct chemical properties, give rise to
distinct biological properties.
The pathways described in this review
show how enzymes take advantage of
the inherent reactivity of L-tryptophan to
generate divergent natural products. One
feature of the indole ring of L-tryptophan
(Figures 1A and 1F) is the potential reac-
tivity of the C2, as well as the C4, C5, C6,
and C7, carbons in electrophilic aromatic substitution reactions
(Figure 1F). Enzymatic derivatization, including chlorination,
hydroxylation,andprenylation, occursatasubsetof thesecarbons
in each of the biosynthetic pathways described in this review.
Oxidation of L-tryptophan to either indole-3-pyruvate imine or
to indole-3-pyruvic acid increases its reactivity, and this strategy
is used in making each of the three classes of compounds
described in this review. In both the indolo[2,3-a]pyrrolo[3,4-c]
carbazole and the violacein pathways, conversion to indole-3-
pyruvate imine generates a substrate suitable for an enzymati-
cally catalyzed oxidative dimerization of two indole-3-pyruvate
imine molecules at the Cb carbons (Figure 1G). This intermediate
10 (Figure 1H) can spontaneously collapse, giving rise to chromo-
pyrrolic acid 11 (Figure 1I), a precursor suitable for a series of
subsequent enzymatic transformations (Figures 1I and 1J). Alter-
nately, as in the violacein pathway, the same intermediate 10 can
break down through an alternate route. Instead of formation of
a pyrrolo ring, a cyclopropyl ring can form and collapseChemistry & Biology 16, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 353
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alternate pathway leads to the [1,2] migration of an indole ring,
generating a new, rearranged carbon skeleton and a violacein
precursor.
Additional opportunities for dimerization and cyclization
emerge via formation of indole 3-pyruvate from L-tryptophan.
As exemplified by the terrequinone A biosynthetic cluster, teth-
ering of the carboxylate of indole-3-pyruvate as a thioester on
a carrier protein generates an electrophile at the carbonyl
carbon, which can be subjected to nucleophilic attack by
another indole-3-pyruvate molecule (Figure 1L). Hence, the rich
chemistry of L-tryptophan provides a template for production
of a diversity of bisindole natural products.
Indolo[2,3-a]pyrrolo[3,4-c]carbazoles
The most frequently isolated bisindole molecules are indolocar-
bazoles (structure of carbazole 2 in Figure 1B), and, among indo-
locarbazoles, the most common are indolo[2,3-a]carbazoles 3
(Figure 1C). Among this subgroup, the most widespread are in-
dolo[2,3-a]pyrrolo[3,4-c]carbazoles 4 (Figure 1D). Dimerization
of L-tryptophan molecules via their Cb carbons gives rise to
a connectivity that favors formation of this core indolo[2,3-a]pyr-
rolo[3,4-c]carbazole structure, which may explain its prevalence
(Figures 1G–1I). Recently, gene clusters encoding proteins
needed to biosynthesize four indolo[2,3-a]pyrrolo[3,4-c]carba-
zoles, rebeccamycin 17, AT2433-A1 38, staurosporine 18, and
K252a 39, have been isolated and characterized (Table 1). Re-
beccamycin and AT2433-A1, on one hand, and staurosporine
and K252a, on the other, represent two types of indolo[2,3-a]pyr-
rolo[3,4-c]carbazoles. Rebeccamycin and AT2433-A1 are chlori-
nated, contain a fully oxidized C-7 carbon (numbering, Fig-
ure 1D), and bear a b-glycosidic bond to only one indole
nitrogen. In contrast, staurosporine and K252a are not haloge-
nated, contain a fully reduced C-7 carbon, and contain a sugar
attached to both indole nitrogens (Table 1). Three parts of the
biosynthetic pathways are thus distinct between the two groups:
(1) halogenation, (2) oxidation of the C-7 carbon, and (3) glycosyl-
ation. Because the rebeccamycin and staurosporine bio-
synthetic pathways are the best studied, only details for these
pathways will be reviewed here (see pathways in purple, red,
and blue in Figure 2), although initial information about the
molecular details of AT2433-A1 and K252a construction is now
available (Gao et al., 2006; Kim et al., 2007).
Chlorination of L-tryptophan is the first step in rebeccamycin
biosynthesis; however, the presence of a chlorine atom is appar-
ently not essential to substrate recognition in later steps in rebec-
camycin biosynthesis, as des-chloro substrates are utilized by all
of the downstream rebeccamycin biosynthetic enzymes (Sa´n-
chez et al., 2005). Additionally, many of the subsequent enzymesChemistry & Bin the pathway are also able to accept alternately halogenated
substrates; however, yields are lower with such modifications
(Sa´nchez et al., 2005). In rebeccamycin biosynthesis, chlorina-
tion occurs via the FADH2-dependent halogenase RebH, with
FADH2 generated by the partner flavin reductase, RebF (Figure 2)
(Yeh et al., 2005). The crystal structure of RebH reveals that there
are two active sites in RebH: one where FADH2, Cl
, and O2 bind
and, 11 A˚ away, a second site where L-tryptophan binds.
Occluding the tunnel between the active sites is the conserved
amino acid lysine-79 (Figure 3A) (Bitto et al., 2008; Yeh et al.,
2007). Biochemical analysis of RebH suggests that chlorination
occurs in two kinetic phases (Yeh et al., 2006), with generation
of a stable intermediate on RebH. It has been proposed that
reduced flavin reacts with oxygen and then a chloride ion to
generate hypochlorite (HOCl). Based on the stability of the inter-
mediate in the protein, with a half-life of 28 hr at room tempera-
ture (Yeh et al., 2007), but the rapid decomposition of HOCl in
solution, it has been suggested that RebH may use lysine-79
to generate a chloramine intermediate on its terminal 3-NH2.
This chloramine intermediate would then act as a transferring
agent to bring HOCl generated from FADH2 in the first reaction
to L-tryptophan bound at a distant site in the protein (Yeh
et al., 2007). Structural and mechanistic studies of the highly
related tryptophan chlorinase PrnA have also provided consider-
able insight into RebH and led to suggestion of an alternate reac-
tion mechanism (Dong et al., 2005; Flecks et al., 2008). RebH
provides an example of the interesting chemistry one finds in
the bisindole biosynthetic pathways.
RebO, the next enzyme in the pathway, uses FAD to convert
7-chloro-L-tryptophan to its corresponding imine, with a 57-
fold greater kcat/Km for 7-chloro-L-tryptophan than for L-trypto-
phan itself (Nishizawa et al., 2005). Identification of 7-chloro-L-
tryptophan as the preferred substrate suggests that RebO
provides a control point between primary and secondary metab-
olism by utilizing a nonproteogenic amino acid as a substrate
(Nishizawa et al., 2005). StaO, the corresponding enzyme from
the staurosporine pathway (Onaka et al., 2002), is likely to carry
out an identical reaction, but its physiological substrate is L-tryp-
tophan, and StaO is not likely to provide such a control point
between primary and secondary metabolism.
The indole-3-pyruvate imine 8 generated by RebO, which
is not stable in solution, is thought to be channeled to the
next enzyme, RebD, which is an 113 kDa protein and putative
dimer that contains three equivalents of iron, with two as
heme iron (Howard-Jones and Walsh, 2005). Isotopic labeling
experiments demonstrated that the product of RebO, indole-3-
pyruvate imine, rather than its decomposition product, indole-
3-pyruvic acid, is indeed the preferred substrate for RebD
(Howard-Jones and Walsh, 2005). RebD’s use of the reactiveFigure 2. Divergent Pathways in Bisindole Biosynthesis
These pathways are responsible for generating three classes of bisindole molecules. Indolo[2,3-a]pyrrolo[3,4-c]carbazole is represented here by rebeccamycin
17 and staurosporine 18 in red and blue, respectively, violacein 21 in green, and bisindolylquinone by terrequinone A 24 in black. Intermediates shared by more
than one pathway are in purple and the L-tryptophan precursor is in tan. R = Cl for rebeccamycin precursors; R = H for staurosporine and violacein precursors.
Compounds in boxes are characterized intermediates, whereas compounds that are not boxed are proposed but yet uncharacterized intermediates. Double
boxes indicate final products or the L-tryptophan starting material. The proposed mechanism for TdiA-catalyzed production of didemethylasterriquinone D is
shown in Figure 4B. 6, L-tryptophan; 7, 7-chloro-L-tryptophan; 8, indole-3-pyruvate imine; 9, indole-3-pyruvate; 10, Cb-Cb benzylically coupled iminophenylpyr-
uvate dimer; 11, chromopyrrolic acid; 12, K252c (staurosporine aglycone); 13, dichloro-arcyriaflavin A (rebeccamycin aglycone); 14, holyrine A; 15, 40-demethyl-
rebeccamycin; 16, O-demethyl-N-demethyl-staurosporine; 17, rebeccamycin; 18, staurosporine; 19, prodeoxyviolacein; 20, proviolacein; 21, violacein; 22,
didemethylasterriquinone D; 23, ochrindole D; 24, terrequinone A.iology 16, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 355
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biosynthetic enzyme that stabilizes and channels a reactive inter-
mediate to a desired product. It is thought that RebD, as well as its
functional homologs, StaD, from the staurosporine pathway, and
VioB, from the violacein pathway, acts to install a carbon-carbon
bond between the two Cb carbons of two molecules of indole-
pyruvate imine, generating the Cb benzylically coupled imino-
phenylpyruvate dimer 10, with spontaneous chemistry resulting
in production of chromopyrrolic acid 11, the final product and
substrate for subsequent enzymes (Balibar and Walsh, 2006;
Howard-Jones and Walsh, 2005; Nishizawa et al., 2006).
Both StaP and RebP, enzymes with 54% identity from the
staurosporine and rebeccamycin biosynthetic pathways,
respectively, are functionally equivalent cytochrome P450
enzymes that react with chromopyrrolic acid 11 (Sa´nchez et al.,
2005). Only one of the two enzymes, StaP, has been studied
extensively, but all results are thought to extend to its homolog,
RebP. The crystal structure of StaP (Figure 3B) shows the bound
substrate chromopyrrolic acid in the active site of StaP with its
indole rings turned away from one another (Makino et al., 2007).
The orientation of chromopyrrolic acid 11, which appears to be
‘‘locked’’ into place by extensive interactions with the StaP active
site, strongly suggests that the reaction occurs at the C10 carbon
of chromopyrrolic acid. The heme iron and the C10 atom are 4.7 A˚
apart (Makino et al., 2007), a distance that is within range of
substrate-iron distances in other cytochrome P450 enzymes
(Cupp-Vickery and Poulos, 1995; Poulos et al., 1985). In contrast,
the carboxylates are >8 A˚ from the heme iron, which is too far for
Figure 3. Active Sites of Bisindole
Biosynthetic Enzymes
(A) RebH, an FADH2-dependent chlorinase,
contains two active sites, separated by 11 A˚.
FAD (in green; PDB ID 2OAL), L-tryptophan (in
orange; PDB ID 2E4G), and Lys-79 (in magenta)
are shown (Yeh et al., 2007).
(B) StaP (PDB ID 2Z3U) (Makino et al., 2007),
a cytochrome P450 enzyme, binds chromopyrrolic
acid (shown in yellow) with a distance of 4.7 A˚ from
one C10 carbon to its heme iron (brown sphere;
porphyrin ring in red).
(C) RebC (PDB ID 2R0G) (Ryan et al., 2007), a puta-
tive flavin hydroxylase (FAD shown in blue), binds
a tautomer of 7-carboxy-K252a (shown in pink).
Two arginines (in gray) hydrogen bond to the
out-of-plane carboxylate of the 7-carboxy-K252c
tautomer.
(D) VioE, an enzyme with no cofactors, metals, or
single essential side chain, has been cocrystal-
lized with PEG (in green; from PDB ID 3BMZ
[Ryan et al., 2008]) and two molecules of phenyl-
pyruvic acid (from PDB ID 2ZF4 [Hirano et al.,
2008], not shown) in its putative active site. Nearby
are 6 residues (in gray) that play a role in the enzy-
matic acceleration of prodeoxyviolacein produc-
tion (Hirano et al., 2008; Ryan et al., 2008).
interaction (Makino et al., 2007). A
proposed reaction scheme involves
generation of two indole cation radicals,
with subsequent steps enabling aryl-aryl
coupling to occur between the two C2
carbons of the indole rings of chromopyr-
rolic acid (Makino et al., 2007).
StaP must also be considered collectively with downstream
enzymes RebC, from the rebeccamycin pathway, and StaC,
from the staurosporine pathway. Coincubation of StaP with
StaC results in formation of the four-electron oxidation product,
the staurosporine aglycone 12, and coincubation of StaP with
RebC results in formation of the eight-electron oxidation product,
the rebeccamycin aglycone 13 (Howard-Jones and Walsh,
2006). While both enzymes RebC and StaC contain sequence
homology to flavin-dependent oxygenases, only RebC is copuri-
fied with FAD (Howard-Jones and Walsh, 2006). The crystal
structure of RebC, solved with a decomposition product of
aryl-aryl-coupled chromopyrrolic acid trapped in the active
site, shows flavin in an appropriate position to carry out flavin-
based chemistry on the C7 carbon (Figure 3C). The intermediate
trapped in the RebC active site decomposes within 30 min in
solution (Howard-Jones and Walsh, 2007), yet a RebC crystal
is able to stabilize the same molecule over a week-long time
span, suggesting the role of RebC is to stabilize a reactive inter-
mediate as well as to carry out oxidative chemistry at the C7
carbon (Ryan et al., 2007). StaC, which is purified without FAD
(Howard-Jones and Walsh, 2006), may be an enzyme that acts
without flavin-based hydroxylation chemistry and primarily acts
in stabilizing reactive intermediates. In any case, stabilization of
reactive intermediates is likely a key function of both enzymes.
After formation of the rebeccamycin or staurosporine agly-
cones, further modification occurs via glycosylation and methyla-
tion. In the rebeccamycin pathway, a b-glycosidic bond is
installed between one indole nitrogen and a molecule of glucose356 Chemistry & Biology 16, April 24, 2009 ª2009 Elsevier Ltd All rights reserved
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the glucose is methylated by RebM (Zhang et al., 2006). RebG
exhibits flexibility in the indoles it can glycosylate and RebM
exhibits flexibility in the sugars it can methylate (Zhang et al.,
2006). In the staurosporine pathway, glucose is converted via
the action of enzymes StaA, StaB, StaE, StaJ, StaI, and StaK to
NTP-L-ristosamine (Onaka et al., 2002; Salas et al., 2005). L-ris-
tosamine is then installed on the staurosporine aglycone at one
indole nitrogen by the action of StaG; re-orientation of the sugar
into the unfavored 1C4 conformation is followed by attachment
to the second indole nitrogen by the action of StaN (Figure 2)
(Salas et al., 2005). Both StaG and StaN are able to use alternate
sugars as substrates, suggesting flexibility in substrate specificity
(Salas et al., 2005). Following attachment, O-methylation at the
40-amine of L-ristosamine and N-methylation at the 30-hydroxyl
of L-ristosamine occurs by the action of StaMA and StaMB,
respectively (Salas et al., 2005). More details on sugar biosyn-
thesis and attachment are available in an earlier review of bis-
indole biosynthesis (Sa´nchez et al., 2006b). Production of rebec-
camycin in anEscherichia colihosthas also been described (Hyun
et al., 2003).
Violacein
Although the violacein (Table 1) biosynthetic operon was origi-
nally annotated as a four-gene cluster (vioABCD) in a number
of separate studies (August et al., 2000; Brady et al., 2001; Brazil-
ian National Genome Project Consortium, 2003), it was later
discovered that an additional gene, vioE, is necessary for
pigment production (Balibar and Walsh, 2006; Sa´nchez et al.,
2006a). Recent studies have shown that VioA is the first enzyme
in the five enzyme violacein biosynthetic pathway (see purple
and green pathways in Figure 2) (Balibar and Walsh, 2006; Sa´n-
chez et al., 2006a). VioA, which has been shown to be function-
ally equivalent to RebO and StaO from the rebeccamycin and
staurosporine biosynthetic pathways (Sa´nchez et al., 2006a), is
a flavin-dependent L-amino acid oxidase, converting L-trypto-
phan to indole-3-pyruvate imine 8 (Balibar and Walsh, 2006).
VioB, the second enzyme in the violacein biosynthetic pathway,
is a close homolog of RebD and StaD (Balibar and Walsh, 2006),
suggesting a relationship, as for VioA, with indolo[2,3-a]pyr-
rolo[3,4-c]carbazole biosynthetic pathways. Multiple studies
have established that this sequence homology translates to
functional equivalence, and the combination of VioA and VioB
results in the same product (chromopyrrolic acid 11) as the
combination of RebO and RebD (Balibar and Walsh, 2006; Sa´n-
chez et al., 2006a). Additionally, incubation of RebO, RebD, and
later enzymes of the violacein pathway (VioCDE) results in viola-
cein production (Sa´nchez et al., 2006a), further demonstrating
the equivalence of VioAB with RebOD and suggesting a close
evolutionary relationship between the two pathways. However,
production of chromopyrrolic acid 11 by VioAB is not on pathway
to violacein. Chromopyrrolic acid 11 is a shunt product and not
a precursor to violacein (Balibar and Walsh, 2006; Sa´nchez
et al., 2006a). A filtration-HPLC assay established that VioE,
the next enzyme in the pathway, acts on an as yet uncharacter-
ized intermediate produced by VioB to generate prodeoxyviola-
cein 19 (Balibar and Walsh, 2006). Based on the ability of VioE to
produce prodeoxyviolacein 19 from the VioB product, a likely
reaction for both VioB and RebD to catalyze is the dimerizationChemistry & Bof two molecules of indole-3-pyruvate imine to give the Cb-Cb
benzylically coupled iminophenylpyruvate dimer 10, a molecule
which can spontaneously decompose to chromopyrrolic acid
11 in the absence of VioE. If the coupled iminophenylpyruvate
dimer is indeed the substrate of VioE, then VioE is required to
mediate a 1,2 shift of an indole ring, closure of the pyrrolo ring,
two decarboxylations, and additional oxidative chemistry (Fig-
ure 2). Despite carrying out these many reactions, VioE, a protein
with few sequence homologs, lacks any detectable cofactors or
metals, as judged by biochemical (Balibar and Walsh, 2006) as
well as subsequent crystallographic analysis (Hirano et al.,
2008; Ryan et al., 2008). The crystal structures of VioE reveal
a dimeric, 11-stranded antiparallel b sheet. Two sets of site-
directed mutagenesis experiments demonstrated 6 residues in
the active site that are important, but not essential, to catalysis
(Figure 3D), based on the decrease in product formation upon
mutation of any of these residues to alanine. From crystallo-
graphic analysis, it appears that VioE may function by orienting
a substrate in the cleft of its surface, such that steric effects
promote production of prodeoxyviolacein and suppress forma-
tion of the shunt product chromopyrrolic acid 11 (Hirano et al.,
2008; Ryan et al., 2008).
The product of VioE-mediated catalysis, prodeoxyviolacein 19,
is in turn the substrate for VioD, a flavin-dependent enzyme. VioD
hydroxylates prodeoxyviolacein in the presence of NAD(P)H,
generating proviolacein 20 (Balibar and Walsh, 2006). VioC,
another flavin-dependent enzyme that requires NAD(P)H for
activity, is then responsible for oxygenation in the oxindole ring.
Although VioC is able to react with either prodeoxyviolacein 19
(the VioE product) or proviolacein 20 (the VioD product), VioD is
only able to react with prodeoxyviolacein 19 (the VioE product),
suggesting that VioD acts before VioC in the biosynthetic
pathway (Balibar and Walsh, 2006). This pathway order is also
consistent with in vivo results (Sa´nchez et al., 2006a).
Bisindolylquinones
Terrequinone A (Table 1), the only bisindoylquinone for which
biosynthetic information is available, was first isolated from the
fungus Aspergillus terreus, residing in the rhizosphere of canyon
ragweed (Ambrosia ambrosioides) from the Tucson Mountains of
Arizona (He et al., 2004). One cluster of five genes was identified
from the related species Aspergillus nidulans and found to
encode five enzymes, TdiABCDE, which were shown to biosyn-
thesize terrequinone A (Bok et al., 2006).
The first step in terrequinone A construction (see pathway in
black in Figure 2) is the pyridoxal-50-phosphate-dependent reac-
tion of TdiD with L-tryptophan, generating indole pyruvic acid 9
(Balibar et al., 2007; Schneider et al., 2007). The cosubstrate is
phenylpyruvic acid (Schneider et al., 2007). This first biosynthetic
step immediately separates terrequinone A biosynthesis from
indolocarbazole and violacein biosynthesis, as these pathways
use indole-3-pyruvate imine 8 as a precursor, rather than
indole-3-pyruvic acid 9. One key chemical issue in production
of indole pyruvic acid (as for the imine) is its instability. However,
TdiA, the next enzyme in the terrequinone A pathway reacts with
indole-3-pyruvic acid with a KM of 1.2 ± 0.3 mM, suggesting that
the instability of the indole-3-pyruvic acid produced by TdiD is
countered by the high affinity for this molecule by TdiA (Balibar
et al., 2007).iology 16, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 357
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(A) Standard NRPS’s construct peptides using an assembly-like construction. The enzymes are modular, with each module containing domains, which can
include A (adenylation domain, responsible for activating an amino acid), T (thiolation domain, which tethers the amino acid or peptide via a phosphopantetheinyl
arm; shown as a squiggly line), C (condensation, responsible for amide bond formation), and TE (thioesterase, responsible for release of the final peptide product).
Long peptides can be generated by iterative rounds of amide bond formation, with each step catalyzed by a distinct module. In a final stage, the elongated
peptide is transferred to an active site serine on the TE domain. Release of the peptide from the enzyme can occur by hydrolysis, giving rise to an acid, or cycli-
zation, giving rise to either an ester or an amide linkage.
(B) TdiA is thought to use a nonstandard NRPS-like chemistry to generate the terrequinone A precursor. Instead of utilizing amino acids, TdiA reacts with an a-keto
acid, indole-3-pyruvic acid, although, as for standard NRPS’s, it activates it via an adenylation reaction. Rather than using one module per substrate, TdiA tethers
two indole-3-pyruvate substrates on adjacent domains of one module. Finally, TdiA lacks a condensation domain and instead is thought to use two mixed Claisen
condensation reactions to generate the didemethylasterriquinone 22 product.TdiA represents a novel enzyme. Bioinformatic analysis
suggests that TdiA is a nonribosomal peptide synthetase
(NRPS) (Figure 4A) with the following three domains: adenylation
(A), thiolation (T), and thioesterase (TE). However, TdiA has many
unusual features and since it does not catalyze the formation of
peptide bonds, it may be appropriate to term this type of enzyme
a ‘‘quinone synthetase,’’ rather than an NRPS. Also, in contrast
to most NRPS enzymes, it is a single module, lacks the canonical
condensation (or replacement cyclization) domain, and may use
a new mechanism of release from the thioesterase domain. A
new mechanism of release from the thioesterase domain is
needed because terrequinone A lacks an acid, amide, or ester
group that would be generated by a hydrolysis or cyclization358 Chemistry & Biology 16, April 24, 2009 ª2009 Elsevier Ltd All rigreaction on the thioesterase (Figure 4A) (Balibar et al., 2007).
Additionally, its putative substrate is not, as is typical, an amino
acid, but instead is an a-keto acid (Figure 4B).
The holoenzyme TdiA, which has a phophopantetheinyl arm
loaded on the T domain (indicated by squiggly line attached to
SH in Figure 4), produces the bisindole product didemethylaster-
riquinone D 22 from two molecules of indole-3-pyruvic acid
(Balibar et al., 2007; Schneider et al., 2007). Both the T and the
TE domains of TdiA are necessary for this activity, as neither
an unloaded T domain with an active TE domain nor a TE domain
with a mutation at a conserved serine with an active T domain
produce didemethylasterriquinone D 22 (Balibar et al., 2007).
With two molecules of indole-3-pyruvate loaded onto TdiA (onehts reserved
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the serine of the TE domain), a plausible reaction scheme
involves two mixed Claisen condensations to give rise to the final
product (Figure 4B). This type of condensation reaction is a yet
unknown chemistry for NRPS domains and represents the first
reported NRPS-like protein that can catalyze carbon-carbon
bond formation (Balibar et al., 2007; Schneider et al., 2007).
The ability of TdiA to dimerize two indole pyruvate molecules
by tethering them on adjacent T and TE domains of a single
module enzyme explains both the need for only one NRPS-like
module, as well as the lack of amide, ester, or acid linkages
connecting two indole pyruvate molecules in the final product
didemethylasterriquinone D 22.
Subsequent enzymes in the biosynthetic pathway have been
shown to be even more unusual than TdiA. While these final three
enzymes, TdiC, TdiB, and TdiE, are able to generate terrequi-
none A 24 from didemethylasterriquinone D 22 in a reaction
mixture containing NAD(P)H, dimethylallyl pyrophosphate, and
divalent metal ions, none of the three enzymes are able to react
with didemethylasterriquinone D 22 alone (Balibar et al., 2007).
TdiC, a putative NADH-dependent oxidoreductase, is proposed
to transfer a hydride to didemethylasterriquinone D 22, convert-
ing this compound into an electron-rich nucleophile. TdiC,
however, is likely to work in concert with TdiB and TdiE, and
together these enzymes generate the mono-prenylated
compound ochrindole D 23. TdiB is thought to be the prenyl-
transferase and TdiE is thought to impart specificity. Without
TdiE present, an off-pathway prenylation occurs at one of the
hydroxyls; with TdiE present, however, only ochrindole D 23 is
observed. TdiB is then able to react again, on its own, with
ochrindole D 23 to install a second prenyl group, generating
terrequinone A 24 (Balibar et al., 2007).
One of the most fascinating features of TdiB is its ability to
install prenyl groups at two unique sites, at one site through
a ‘‘regular’’ prenylation reaction and at the other site through
a ‘‘reverse’’ prenylation reaction, while avoiding prenylation at
near-identical sites elsewhere on the didemethylasterriquinone
22 scaffold. That is, prenylation occurs at C5 of the quinone
core and C2 of an indole ring (20), but not at C2 of the quinone
core or C2 of the other indole ring (200) (numbering, Figure 1E).
Since 22 is symmetric prior to prenylation, this differentiation
must occur after prenylation. How a single prenyltransferase
can specifically catalyze a prenylation on two unique sites of
the same molecule and avoid prenylation on near-equivalent
sites is still unknown.
It should be noted that two groups came to distinct conclu-
sions regarding the role of TdiB in the biosynthesis of terrequi-
none A. While both groups agree that TdiB catalyzes a prenyla-
tion at the C2 of one indole carbon, they disagree on whether the
substrate is didemethylasterriquinone 22 or ochrindole 23. One
group showed data to suggest a single-enzyme-mediated pre-
nylation of didemethylasterriquinone D 22 at the C2 of one indole
carbon (Schneider et al., 2008), but the other group was unable
to observe a reaction between TdiB and didemethylasterriqui-
none 22. Instead, they observed that TdiB could carry out the
same prenylation reaction on the monoprenylated derivative,
ochrindole D 23, generating the bisindole terrequinone A 24
(Balibar et al., 2007). Despite the differences in observed activity,
it is clear that only one prenylation, on the C2 of one indole ring,Chemistry & Boccurs by the action of TdiB alone (Balibar et al., 2007; Schneider
et al., 2008), and the presence of TdiB, TdiC, and TdiE does allow
prenylation at the C5 of the quinone core to occur (Balibar et al.,
2007). These results suggest a complicated and yet uneluci-
dated relationship between TdiB, TdiC, and TdiE.
Other Bisindole Molecules
The studies described in this review have revealed the biosyn-
thetic steps that lead to construction of the indolo[2,3-a]pyr-
rolo[3,4-c]carbazole core, the violacein skeleton, and the bisin-
dolylquinone skeleton. A number of related molecules may be
biosynthesized through similar pathways and it is worthwhile to
consider the similarities and differences that are likely to exist
between the biosynthesis of rebeccamycin 17, AT2433-A1 38,
staurosporine 18, K252a 39, violacein 21, terrequinone A 24,
and other, related molecules. Based on the variety of bisindole
molecules isolated from nature, however, it is also clear that
some bisindole molecules cannot be understood in terms of in-
dolo[2,3-a]pyrrolo[3,4-c]carbazole, violacein, or bisindolylqui-
none biosynthesis and these molecules are likely to be formed
by unique pathways. The study of bisindole biosynthesis, there-
fore, will be a rich area of investigation for many more years.
One example of a variation on rebeccamycin is the molecule
indocarbazostatin B 25 (Figure 5A) (Matsuura et al., 2002), which
contains a similar aglycone core to rebeccamycin, but differs in
the glycosylation, with glycosylation partially resembling that of
K252a 39. Indocarbazostatin B is also hydroxylated at the C5
position of one indole ring and aminated at the C4 position of
the same ring. Therefore, it is reasonable to anticipate that
bacteria encoding the biosynthetic cluster for indocarbazostatin
B will contain homologs to rebO, rebD, rebP, and rebC but will
differ from the rebeccamycin gene cluster in the presence of
a distinct set of enzymes devoted to hydroxylation and amination
reactions. Additionally, glycosylation enzymes in this pathway
may largely resemble those from the K252a pathway, with
some modifications. More dramatically distinct from rebecca-
mycin and staurosporine is a molecule such as arcyriacyanin A
26 (Figure 5B) (Steglich, 1989), but it is possible that the unusual
linkage in its core structure results from an alternate aryl-aryl
coupling by a StaP substitute (Figure 5B). This step would likely
use a similar chemical strategy to StaP, but with the chromopyr-
rolic acid substrate held in an alternative orientation to that seen
with StaP to facilitate radical coupling between distinct carbons
on the two indole rings. The biosynthesis of granulatimide 27
(Figure 5C) (Britton et al., 2001) may also be similar to the
indolo[2,3-a]pyrrolo[3,4-c]carbazole biosynthetic pathways but
would use one molecule of L-tryptophan and one molecule of
L-histidine as biosynthetic precursors. Molecules related to ter-
requinone A include semicochliodinol B 28 (Figure 5D) (Freden-
hagen et al., 1997), whose biosynthesis should be identical to
terrequinone A biosynthesis through the intermediate dideme-
thylasterriquinone D 22. However, its biosynthetic pathway will
differ in the type of prenyltransferase, as it is prenylated at
a distinct site from either prenylation site in terrequinone A.
Further, the molecule fellutanine A 29 (Figure 5E) (Kozlovskiı
et al., 2000) may also, like terrequinone A, be constructed using
NRPS chemistry, but would use two modules specific for
L-tryptophan, with formation of an amide bond to release the
product. A two-module NRPS system is used to assemble theiology 16, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 359
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However, NRPS-independent pathways have been described
for the production of a diketopiperazine inStreptomyces noursei,
raising the possibility that fellutanine may also be generated
through an NRPS-independent pathway (Lautru et al., 2002).
While the studies presented in this review do clarify the biosyn-
thetic construction of some bisindole natural products, a number
of unusual bisindole molecules are unlikely to be constructed via
the same types of biosynthetic pathways. For instance, although
Figure 6. Unusual Bisindole Molecules
(A) A number of unusual molecules are unlikely to
be constructed by processes that generate in-
dolo[2,3-a]pyrrolo[3,4-c]carbazole cores, the vio-
lacein skeleton, or the bisindolylquinone skeleton.
Each bisindole molecule shown below, however,
could be derived from two dimerized L-tryptophan
molecules. To emphasize this point, the molecules
are drawn with atoms in blue, representing atoms
from one L-tryptophan molecule. Red represents
atoms from a second L-tryptophan molecule.
Note, however, that labeling studies have not es-
tablished the biosynthetic origins of any of these
molecules.
(B) A proposed mechanism for pityriacitrin A
biosynthesis includes the spontaneous reaction
of L-tryptophan 6 with indole-3-pyruvate 9 (Zuther
et al., 2008).
the molecule nortopsentin A 30 (Sakemi
and Sun, 1991) (Figure 5F) appears to
have a similar core skeleton to that of vio-
lacein, nortopsentin A must be generated
through an alternate process. Unlike vio-
lacein, whose biosynthesis involves loss
of a nitrogen, nortopsentin A contains
two nitrogens in its central ring. Other
molecules (Figure 6), including ancorina-
zole 31 (Meragelman et al., 2002), the
cytotoxin cladoniamide G 32 (Williams
et al., 2008), the DNA intercalating agent
fascaplysin 33 (Ho¨rmann et al., 2001;
Kirsch et al., 2000), tjipanazole I 34 (Bon-
jouklian et al., 1991), rhopaladin A 35
(Sato et al., 1998), and the cytotoxin ihey-
amine B 36 (Sasaki et al., 1999), whose
indole rings may be derived from L-tryp-
tophan, are likely to be generated by yet
unexplored pathways (Figure 6A). A
recent, exciting result is the finding that
spontaneous oxidative reaction between
L-tryptophan and indole-3-pyruvate is
responsible for the production of a variety
of pigments including pityriacitrin 37
(Zuther et al., 2008). Inactivation of the tam1 gene, which
encodes an L-tryptophan aminotransferase in the plant path-
ogen Ustilago maydis, abolishes production of each of these
pigments (Zuther et al., 2008). Many of the pigments, including
pityriacitrin 37, can be produced, however, by simply incubating
the product of Tam1 catalysis, indole-3-pyruvate, with L-trypto-
phan (Zuther et al., 2008) (Figure 6B). This unexpected discovery
suggests that spontaneous chemistry, already thought to play
a role in key steps of indolo[2,3-a]pyrrolo[3,4-c]carbazole,Figure 5. Underexplored Bisindole Products
Possible biosynthetic routes are shown.
(A) Indocarbazostatin B 25.
(B) Arcyriacyanin A 26.
(C) Granulatimide 27.
(D) Semicochliodinol B 28.
(E) Fellutanine A 29. NRPS domains are shown in boxes (A, adenylation; T, thiolation; C, condensation; TE, thioesterase).
(F) Nortopsentin A 30.Chemistry & Biology 16, April 24, 2009 ª2009 Elsevier Ltd All rights reserved 361
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responsible for production of a series of bisindole pigments.
The specific routes to spontaneous production of these
pigments should be a rich area for future study and it is tempting
to speculate that spontaneous chemistry may play a role in
production of a variety of yet unexplored bisindole biosynthetic
pathways.
Future Directions in Bisindole Biosynthesis
Although studies have clarified the role of many of the enzymes
involved in the construction of the three types of bisindole mole-
cules presented in this review, a number of questions remain
about the details of these enzymatic reactions. In rebeccamycin
biosynthesis, spectroscopic or structural elucidation of the
proposed Lys-79-chloramine intermediate in RebH is still lack-
ing, as is an understanding of how FADH2 produced by the
partner reductase RebF is transferred to RebH. The structure
of RebD, which is not yet available, would represent a largely un-
characterized enzyme. It also might shed light on how RebD,
which has three equivalents of iron (Howard-Jones and Walsh,
2005), can be functionally identical to VioB, which has less
than one equivalent of iron (Balibar and Walsh, 2006), as well
as provide details about potential routes for the proposed chan-
neling of indole-3-pyruvate imine from RebO to RebD. For the
two-enzyme RebP-RebC system, although a series of studies
suggest that an unstable intermediate is produced by RebP
and is the substrate of RebC (Howard-Jones and Walsh, 2006,
2007; Ryan et al., 2007), questions of intermediate channeling,
the precise identity of the substrate of RebC, and the mechanism
of flavin based hydroxylation chemistry are areas of active study.
Further, in the staurosporine pathway, questions remains about
the role of StaC, which is a close homolog of RebC but is purified
without bound FAD and carries out a distinct reaction (Howard-
Jones and Walsh, 2006). In the violacein pathway, a number of
questions are also outstanding. Although an intermediate has
been shown to be transferred from VioB to VioE, the identity of
this intermediate has only been suggested (Balibar and Walsh,
2006). Further, while structural characterization now provides
a model of VioE (Hirano et al., 2008; Ryan et al., 2008), the lack
of an essential residue in VioE is puzzling and the mechanistic
chemistry involved in converting the Cb-Cb benzylically coupled
iminophenylpyruvate dimer 10 to prodeoxyviolacein 19 is largely
unexplored. Next, VioD, while apparently a ‘‘standard’’ flavin
hydroxylase, will hydroxylate prodeoxyviolacein but not the
related molecule oxyviolacein (Balibar and Walsh, 2006), sug-
gesting either steric or electronic effects modulate its substrate
specificity. In the bisindolylquinone pathways, exemplified by
the terrequinone A biosynthetic pathway, only TdiD is reasonably
well understood. For TdiA, the mechanistic details of how dide-
methylasterriquinone 22 is generated still await exploration, as
the mixed Claisen condensations could occur with either the T
domain-tethered or the TE domain-tethered indole-3-pyruvate
acting as a nucleophile. For TdiB, TdiC, and TdiE, available
data suggest a complicated relationship between the three
enzymes (Balibar et al., 2007) and further studies will be needed
to delineate how TdiE accelerates the TdiB-TdiC-mediated
production of terrequinone A 24 from didemethylasterriquinone
D 22. For many of the bisindole biosynthetic enzymes, whose
roles include enzymatic reactions and stabilization of reactive362 Chemistry & Biology 16, April 24, 2009 ª2009 Elsevier Ltd All rigpathway intermediates, standard biochemical approaches are
often difficult, particularly when putative substrates and prod-
ucts decompose quickly in solution.
Major questions also remain about the roles of these mole-
cules for their producing organisms. For instance, staurosporine
is often isolated as a natural product (Sa´nchez et al., 2006b); why
do many actinomycete bacteria invest biochemical energy to
produce a protein kinase inhibitor such as staurosporine? Addi-
tionally, what is the physiological role of violacein; is it related to
its various biochemical properties, including antibacterial, anti-
viral, and antiprotozoan properties (Dura´n and Menck, 2001;
Matz et al., 2008), to its apparent regulation with quorum-sensing
pathways (McClean et al., 1997), or to its distinctive purple
color? Finally, why do plant-associated fungi such as Aspergillus
nidulans produce molecules such as terrequionone A, which has
unknown properties? Is there a yet unexplored role for terrequi-
none A that is relevant to its role in its ecological niche? One fron-
tier in the basic science research of bisindole natural products is
a detailed investigation of the ecological interactions mediated
by natural products such as rebeccamycin, staurosporine, viola-
cein, and terrequinone A.
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